 |
NewBridge inks Abstral distribution dealDubai-based NewBridge Pharmaceuticals has signed an exclusive licensing and distribution agreement with Orexo AB to market Abstral, a key product for treatment of breakthrough cancer pain, in the Middle East and Africa region. A specialty More… |
Saturday 4 May 2024
